Get started Log in

PCSA — Processa Pharmaceuticals Share News

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMicro CapSucker Stock

Processa Pharmaceuticals Inc expected to post a loss of 10 cents a share - Earnings Preview
03/11/2023 12:38
Brief: Processa Pharmaceuticals Announces Formation Of Oncology Advisory Board
01/11/2023 12:26
U.S. STOCKS ON THE MOVE-Tesla, Netflix, Foot Locker
19/10/2023 13:52
U.S. STOCKS ON THE MOVE-Pfizer, Lululemon Athletica, Maxeon Solar
16/10/2023 12:40
Brief: Processa Pharmaceuticals Says On Sept 19, Got Notice Of Delisting Or Failure To Satisfy A Continued Listing Rule Or Standard From Nasdaq
21/09/2023 22:41
Brief: Processa Pharma Provides Data Update Supporting Potential Personalized Treatment Approach For Improved Cancer Care
17/08/2023 14:23
Brief: Processa Pharmaceuticals Appoints Life Sciences Industry Veteran George Ng As Chief Executive Officer
08/08/2023 14:23
Brief: Processa Pharmaceuticals To Conduct Next Generation Chemotherapy-Capecitabine Phase 2 Trial Based On FDA Guidance And Project Optimus Oncology Initiative
18/05/2023 13:08
Processa Pharmaceuticals Inc expected to post a loss of 28 cents a share - Earnings Preview
09/05/2023 24:42
Processa Pharmaceuticals Inc reports results for the quarter ended in December - Earnings Summary
30/03/2023 22:56
Brief: Processa Pharmaceuticals Provides Corporate Update And Announces Year End 2022 Financial Results
30/03/2023 21:40
Processa Pharmaceuticals Inc expected to post a loss of 32 cents a share - Earnings Preview
28/03/2023 22:03
Brief: Processa Pharmaceuticals To Host Conference Call To Discuss 2022 Year End Results And Provide Drug Development Update On March 30, 2023 At 430 P.M. Est
23/03/2023 12:58
Brief: Processa Pharmaceuticals Receives Notice Of Delisting From Nasdaq
22/03/2023 21:51
Brief: Processa Pharmaceuticals Announces First Patient Dosed In 300 Mg Dose Group With Next Gen Chemotherapy-Capecitabine
17/03/2023 13:20
Brief: Processa Pharma Announces Prioritization On Development Of Next Gen Chemotherapies
21/02/2023 14:26
Brief: Processa Pharmaceuticals, Inc. Announces Closing Of $6.25 Million Registered Direct Offering, Which Included Retail Investors And Insiders, Priced At The Market Under Nasdaq Rules
15/02/2023 14:16
Brief: Processa Pharmaceuticals Announces $6.25 Mln Registered Direct Offering
10/02/2023 13:48
Brief: Processa Pharma Terminates Prospectus Supplement Related To Company's Common Stock, Par Value $0.0001 Per Share
06/02/2023 16:49
Maxim cuts PT on Processa on higher discount rates
12/01/2023 16:02